Plakous Therapeutics, Inc.

Biotechnology company · Winston-Salem, North Carolina, United States

Plakous Therapeutics, Inc. is a biotechnology company headquartered in Winston-Salem, North Carolina, United States. Its earliest recorded incorporation is in 2016. It has received 3 US government small-business research awards (SBIR/STTR) from health agencies, $3.8 million in total, most recently in 2024. It has reported private securities offerings to the US SEC, most recently $175,000 sold in a notice filed in 2020.

www.plakoustherapeutics.comProfile compiled from public records. Is this your company? Request a correction or update

Plakous Therapeutics at a glance

Typebiotechnology company
HeadquartersWinston-Salem, North Carolina, United States
Earliest incorporation on record2016
Employees (self-reported, 2024)3
SEC CIK1709440

What does Plakous Therapeutics do?

US government research funding

3 SBIR/STTR small-business research awards from US health agencies, $3.8 million in total (2020 to 2024). NIH funding came from the National Institute of Child Health and Human Development.

Private fundraising reported to the SEC

2 Form D notices; the most recent reported $175,000 sold (2020).

Frequently asked questions about Plakous Therapeutics

Where is Plakous Therapeutics headquartered?

Plakous Therapeutics, Inc. is headquartered in Winston-Salem, North Carolina, United States.

What does Plakous Therapeutics do?

Plakous Therapeutics, Inc. is a biotechnology company.

When was Plakous Therapeutics founded?

The earliest incorporation on record for Plakous Therapeutics, Inc. is in 2016, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences